Literature DB >> 11283114

Low Prevalence of Community-Acquired Methicillin-Resistant Staphylococcus aureus in Adults at a University Hospital in the Central United States.

N Suntharam1, D Hacek, L R Peterson.   

Abstract

Community-acquired MRSA (CA-MRSA) is potentially a new emerging pathogen with most strains susceptible to many antimicrobials except for beta-lactam antibiotics. We retrospectively reviewed MRSA isolates during a 20-month study period (January 1998 through August 1999) and investigated those that were clindamycin susceptible. Patients were not considered to harbor CA-MRSA if they had been admitted to a hospital within the preceding 2 years or if their isolate had been obtained more than 72 h after admission. There were 2,817 S. aureus isolates, with 1,071 (38%) being MRSA. Of these 1,071 isolates, 161 were clindamycin susceptible; these were recovered from 81 patients. Of these 81 patients, 20 appeared to have community-acquired strains, but only 2 could be confirmed as having CA-MRSA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283114      PMCID: PMC87997          DOI: 10.1128/JCM.39.4.1669-1671.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Increase in community-acquired methicillin-resistant Staphylococcus aureus in children.

Authors:  A L Frank; J F Marcinak; P D Mangat; P C Schreckenberger
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

2.  Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-08-20       Impact factor: 17.586

3.  Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing?

Authors:  J M Boyce
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

4.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

5.  Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors.

Authors:  E J Gorak; S M Yamada; J D Brown
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

6.  Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus.

Authors:  M D Sanford; A F Widmer; M J Bale; R N Jones; R P Wenzel
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

7.  Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community.

Authors:  B Shopsin; B Mathema; J Martinez; E Ha; M L Campo; A Fierman; K Krasinski; J Kornblum; P Alcabes; M Waddington; M Riehman; B N Kreiswirth
Journal:  J Infect Dis       Date:  2000-07-06       Impact factor: 5.226

8.  Hospital- and community-based surveillance of methicillin-resistant Staphylococcus aureus: previous hospitalization is the major risk factor.

Authors:  B Warshawsky; Z Hussain; D B Gregson; R Alder; M Austin; D Bruckschwaiger; A H Chagla; J Daley; C Duhaime; K McGhie; G Pollett; H Potters; L Schiedel
Journal:  Infect Control Hosp Epidemiol       Date:  2000-11       Impact factor: 3.254

9.  Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory.

Authors:  G P Maguire; A D Arthur; P J Boustead; B Dwyer; B J Currie
Journal:  Med J Aust       Date:  1996-06-17       Impact factor: 7.738

10.  Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992.

Authors:  J Embil; K Ramotar; L Romance; M Alfa; J Conly; S Cronk; G Taylor; B Sutherland; T Louie; E Henderson
Journal:  Infect Control Hosp Epidemiol       Date:  1994-10       Impact factor: 3.254

View more
  4 in total

1.  Use of ribotyping to retrospectively identify methicillin-resistant Staphylococcus aureus isolates from phase 3 clinical trials for tigecycline that are genotypically related to community-associated isolates.

Authors:  Fionnuala McAleese; Ellen Murphy; Timothy Babinchak; Guy Singh; Battouli Said-Salim; Barry Kreiswirth; Paul Dunman; John O'Connell; Steven J Projan; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

Review 2.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia.

Authors:  F G O'Brien; T T Lim; F N Chong; G W Coombs; M C Enright; D A Robinson; A Monk; B Saïd-Salim; B N Kreiswirth; W B Grubb
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

4.  Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates.

Authors:  Michael Z David; Susan E Crawford; Susan Boyle-Vavra; Mark A Hostetler; Daniel C Kim; Robert S Daum
Journal:  Emerg Infect Dis       Date:  2006-04       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.